Hwang Y, Oh J
Int J Mol Sci. 2025; 26(3).
PMID: 39940928
PMC: 11818468.
DOI: 10.3390/ijms26031160.
Sysoeva O, Akhmirov R, Zaichenko M, Lazarenko I, Rebik A, Broshevitskaja N
Diagnostics (Basel). 2025; 15(2).
PMID: 39857035
PMC: 11764329.
DOI: 10.3390/diagnostics15020151.
Alexander L, Young A
BJPsych Adv. 2024; 29(2):117-130.
PMID: 39649121
PMC: 7617086.
DOI: 10.1192/bja.2022.14.
Su Z, Chen Z, Cao J, Li C, Duan J, Zhou T
Clin Psychopharmacol Neurosci. 2024; 22(4):594-609.
PMID: 39420607
PMC: 11494436.
DOI: 10.9758/cpn.24.1167.
Nishio Y, Lindsley C, Bender A
ACS Chem Neurosci. 2024; 15(21):3863-3873.
PMID: 39382192
PMC: 11587517.
DOI: 10.1021/acschemneuro.4c00519.
Neuritin Controls Axonal Branching in Serotonin Neurons: A Possible Mediator Involved in the Regulation of Depressive and Anxiety Behaviors via FGF Signaling.
Shimada T, Kohyama K, Yoshida T, Yamagata K
J Neurosci. 2024; 44(41).
PMID: 39197941
PMC: 11466069.
DOI: 10.1523/JNEUROSCI.0129-23.2024.
Common Cause Versus Dynamic Mutualism: An Empirical Comparison of Two Theories of Psychopathology in Two Large Longitudinal Cohorts.
Aristodemou M, Kievit R, Murray A, Eisner M, Ribeaud D, Fried E
Clin Psychol Sci. 2024; 12(3):380-402.
PMID: 38827924
PMC: 11136614.
DOI: 10.1177/21677026231162814.
Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder.
Page C, Epperson C, Novick A, Duffy K, Thompson S
Mol Psychiatry. 2024; 29(12):3802-3813.
PMID: 38816586
PMC: 11692567.
DOI: 10.1038/s41380-024-02625-2.
Resource-rational psychopathology.
Bari B, Gershman S
Behav Neurosci. 2024; 138(4):221-234.
PMID: 38753400
PMC: 11423359.
DOI: 10.1037/bne0000600.
N-(3-((3-(trifluoromethyl)phenyl)selanyl)prop-2-yn-1-yl) benzamide induces antidepressant-like effect in mice: involvement of the serotonergic system.
Pires C, da Rocha M, Presa M, Zuge N, Kuntz N, Godoi B
Psychopharmacology (Berl). 2024; 241(8):1663-1678.
PMID: 38635075
DOI: 10.1007/s00213-024-06588-8.
Serotonin effects on human iPSC-derived neural cell functions: from mitochondria to depression.
Cardon I, Grobecker S, Jenne F, Jahner T, Rupprecht R, Milenkovic V
Mol Psychiatry. 2024; 29(9):2689-2700.
PMID: 38532010
PMC: 11420088.
DOI: 10.1038/s41380-024-02538-0.
Inulae Flos has Anti-Depressive Effects by Suppressing Neuroinflammation and Recovering Dysfunction of HPA-axis.
Kim J, Kim J, Eo H, Ju I, Son S, Kim J
Mol Neurobiol. 2024; 61(10):8038-8050.
PMID: 38457106
DOI: 10.1007/s12035-024-04094-8.
Chronic REM sleep deprivation leads to manic- and OCD-related behaviors, and decreases hippocampal BDNF expression in female rats.
Abbasi N, Mirabzadeh Y, Khesali G, Ebrahimkhani Z, Karimi H, Vaseghi S
Psychopharmacology (Berl). 2024; 241(7):1345-1363.
PMID: 38430395
DOI: 10.1007/s00213-024-06566-0.
Understanding the Biological Relationship between Migraine and Depression.
Viudez-Martinez A, Torregrosa A, Navarrete F, Garcia-Gutierrez M
Biomolecules. 2024; 14(2).
PMID: 38397400
PMC: 10886628.
DOI: 10.3390/biom14020163.
Strain in the Midbrain: Impact of Traumatic Brain Injury on the Central Serotonin System.
OConnell C, Brown R, Peach T, Traubert O, Schwierling H, Notorgiacomo G
Brain Sci. 2024; 14(1).
PMID: 38248266
PMC: 10813794.
DOI: 10.3390/brainsci14010051.
High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin.
Braun D, Rosenberg A, Rabaniam E, Haruvi R, Malamud D, Barbara R
Mol Psychiatry. 2024; 29(4):1046-1062.
PMID: 38233467
PMC: 11176078.
DOI: 10.1038/s41380-023-02391-7.
Unlocking Therapeutic Synergy: Tailoring Drugs for Comorbidities such as Depression and Diabetes through Identical Molecular Targets in Different Cell Types.
Coppola T, Daziano G, Legroux I, Beraud-Dufour S, Blondeau N, Lebrun P
Cells. 2023; 12(23).
PMID: 38067196
PMC: 10706795.
DOI: 10.3390/cells12232768.
Techniques for Measurement of Serotonin: Implications in Neuropsychiatric Disorders and Advances in Absolute Value Recording Methods.
Rojas Cabrera J, Oesterle T, Rusheen A, Goyal A, Scheitler K, Mandybur I
ACS Chem Neurosci. 2023; 14(24):4264-4273.
PMID: 38019166
PMC: 10739614.
DOI: 10.1021/acschemneuro.3c00618.
Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression.
Debowska W, Wiedlocha M, Debowska M, Kownacka Z, Marcinowicz P, Szulc A
Front Neurosci. 2023; 17:1267647.
PMID: 37954877
PMC: 10637948.
DOI: 10.3389/fnins.2023.1267647.
Converging circuits between pain and depression: the ventral tegmental area as a therapeutic hub.
Flores-Garcia M, Rizzo A, Garcon-Poca M, Fernandez-Duenas V, Bonaventura J
Front Pharmacol. 2023; 14:1278023.
PMID: 37849731
PMC: 10577189.
DOI: 10.3389/fphar.2023.1278023.
